Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Healthy Subjects”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableStudy completedNCT02287948
What this trial is testing

Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects

Who this might be right for
Postural BalanceMultiple Sclerosis
University Hospital of Ferrara 40
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Not applicableEnded earlyNCT01092208
What this trial is testing

Studies of Autistic Patients: Gene Networks and Clinical Subtypes

Who this might be right for
AutismTuberous Sclerosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 11
Not applicableLooking for participantsNCT00794352
What this trial is testing

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Who this might be right for
Central Nervous System DiseaseMultiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,400
Early research (Phase 1)Study completedNCT04982991
What this trial is testing

Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants

Who this might be right for
Multiple Sclerosis Healthy Subjects
Sanofi 14
Early research (Phase 1)Study completedNCT02442557
What this trial is testing

Safety and Dose-finding Study of DC-TAB in Healthy Subjects

Who this might be right for
Multiple Sclerosis
Delta Crystallon BV 76
Early research (Phase 1)Study completedNCT02517788
What this trial is testing

Phase I BP Interferon (IFN) Beta-004

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Centre Hospitalier Universitaire Vaudois 24
Early research (Phase 1)Not Yet RecruitingNCT04667013
What this trial is testing

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

Who this might be right for
Healthy
Guangzhou Magpie Pharmaceuticals Co., Ltd. 16
Early research (Phase 1)Study completedNCT01466322
What this trial is testing

Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT04022473
What this trial is testing

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Banner Life Sciences LLC 210
Early research (Phase 1)UnknownNCT02364986
What this trial is testing

Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
PD Dr. Marcus Müller 50
Testing effectiveness (Phase 2)Looking for participantsNCT05395624
What this trial is testing

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more
Ashvattha Therapeutics, Inc. 65
Early research (Phase 1)Study completedNCT02641041
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

Who this might be right for
Central Nervous System (CNS) Demyelinating DiseaseMultiple Sclerosis
Biogen 24
Early research (Phase 1)Ended earlyNCT01808482
What this trial is testing

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Post-approval studies (Phase 4)Study completedNCT00913666
What this trial is testing

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 121
Early research (Phase 1)Study completedNCT01431937
What this trial is testing

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 40
Early research (Phase 1)Study completedNCT06064539
What this trial is testing

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Who this might be right for
Multiple Sclerosis
Sanofi 30
Early research (Phase 1)Study completedNCT01699555
What this trial is testing

First-in-Human Study With GNbAC1 in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 33
Early research (Phase 1)Study completedNCT06117020
What this trial is testing

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Who this might be right for
Muscle SpasticityHypertonia, MuscleCerebral Palsy+5 more
Motric Bio 89
Early research (Phase 1)Ended earlyNCT00612872
What this trial is testing

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

Who this might be right for
Parkinson DiseaseAlzheimer DiseaseHealthy Controls+1 more
Institute for Neurodegenerative Disorders 46
Load More Results